AtriCure

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AtriCure and other ETFs, options, and stocks.

About ATRC

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration.

CEO

Michael H. Carrel

CEOMichael H. Carrel

Employees

1,200

Employees1,200

Headquarters

Mason, Ohio

HeadquartersMason, Ohio

Founded

1994

Founded1994

Employees

1,200

Employees1,200

ATRC Key Statistics

Market cap

1.11B

Market cap1.11B

Price-Earnings ratio

-35.09

Price-Earnings ratio-35.09

Dividend yield

—

Dividend yield—

Average volume

812.61K

Average volume812.61K

High today

—

High today—

Low today

—

Low today—

Open price

$23.08

Open price$23.08

Volume

0.00

Volume0.00

52 Week high

$59.61

52 Week high$59.61

52 Week low

$22.27

52 Week low$22.27

ATRC News

Seeking Alpha 2d

AtriCure upgraded at Oppenheimer on valuation

AtriCure (NASDAQ:ATRC) shares traded higher premarket Tuesday after Oppenheimer upgraded the cardiac device maker to Outperform from Perform, citing an attracti...

Yahoo Finance 6d

AtriCure's cryoSPHERE+ Probe to Aid in Pain Management - Yahoo Finance

AtriCure, Inc. ATRC recently announced the launch of the cryoSPHERE+ cryoablation probe, which uses innovative insulation technology to reduce freeze times by 2...

Yahoo Finance 7d

AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management - Yahoo Finance

MASON, Ohio, April 18, 2024--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (A...

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell